Skip to search formSkip to main contentSkip to account menu

ProstaScint Scan

An imaging test used to detect prostate cancer. The patient receives an injection of an indium 111-labeled form of ProstaScint, which contains a… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
  • 2014
  • Corpus ID: 478406
©2016 Blue Cross and Blue Shield of Louisiana An independent licensee of the Blue Cross and Blue Shield Association No part of… 
2008
2008
Hybrid imaging is becoming a popular technology in nuclear medicine. We have evaluated the added value of an integrated SPECT/low… 
2004
2004
In this paper, we evaluate the performance of the previously proposed Compton imaging probe in comparison to SPECT for lesion… 
2004
2004
Indium In 111 capromab pendetide (ProstaScint®; Cytogen Corporation, Princeton, NJ), a radiolabeled monoclonal antibody to… 
2004
2004
Prostate cancer remains the second most common malignancy and cause of death from cancer among men in the United States, despite… 
Review
2000
Review
2000
ZusammenfassungGrundlagen: Fortschritte in der rekombinanten Technologie, die Identifikation neuer Zielmoleküle sowie die M…